Emergence of Clostridium difficile infection in tuberculosis patients due to a highly rifampicin-resistant PCR ribotype 046 clone in Poland

Eur J Clin Microbiol Infect Dis. 2013 Aug;32(8):1027-30. doi: 10.1007/s10096-013-1845-5. Epub 2013 Feb 27.

Abstract

Clostridium difficile infection (CDI) is a major cause of nosocomial diarrhea. CDI is known to develop after antibiotic administration, but anti-tuberculosis agents have rarely been implicated. We documented an outbreak caused by a highly rifampicin-resistant C. difficile strain of polymerase chain reaction (PCR) ribotype 046 in patients with active tuberculosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / pharmacology
  • Antibiotics, Antitubercular / pharmacology
  • Clostridioides difficile / drug effects*
  • Clostridioides difficile / genetics*
  • Clostridioides difficile / isolation & purification
  • Clostridium Infections / microbiology*
  • Cohort Studies
  • Cross Infection / microbiology
  • Disease Outbreaks
  • Drug Resistance, Bacterial
  • Female
  • Hospitalization
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Poland
  • Rifampin / pharmacology*
  • Tuberculosis / microbiology*

Substances

  • Anti-Bacterial Agents
  • Antibiotics, Antitubercular
  • Rifampin